Solid biosciences reports inducement grant to new chief legal officer

Cambridge, mass., march 04, 2021 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company focused on advancing meaningful therapies for duchenne muscular dystrophy (duchenne), today announced the grant of an inducement award to its newly appointed chief legal officer, erin brennan. the grant was approved by a majority of the independent directors of the company on february 25, 2021 as an inducement material to ms. brennan entering into employment with the company in accordance with nasdaq listing rule 5635(c)(4).
SLDB Ratings Summary
SLDB Quant Ranking